Etiology and Clinical Course of Febrile Neutropenia in Child... : Journal of Pediatric
Hematology/Oncology Etiology and Clinical Course of Febrile Neutropenia in Children With …

Background Recent investigations of febrile neutropenia in pediatric cancer patients have
identified subsets of low‐risk patients who can be managed with less antibiotic therapy than …

Purpose To evaluate the feasibility of risk stratification of children with cancer and febrile
neutropenia using a simple set of criteria from data available to the clinician at the time of the …

BACKGROUND. Many studies have succeeded in identifying a subset of children with
febrile neutropenia (FN) who are at lower risk of infectious complications and eventual …

BACKGROUND Fever and neutropenia (F&N) is a common complication of cancer
chemotherapy. It is conveniently managed by hospitalization and empiric administration of …

Purpose To develop an evidence-based guideline for the empiric management of pediatric
fever and neutropenia (FN). Methods The International Pediatric Fever and Neutropenia …

Background There are no standard criteria for when to discontinue intravenous antimicrobial
therapy (IVAMT) in children with febrile neutropenia (FN), but it is now common to …

Febrile neutropenia (FN) is a common and dangerous consequence of myelosuppressive
chemotherapy but can occur as part of the disease processes. Bacterial bloodstream …

Background: Febrile neutropenia is one of the major acute side effects of intensive treatment
in pediatric cancer, necessitating prompt initiation of empirical broad-spectrum antibiotics …

The treatment for most pediatric malignancies is based on systemic, aggressive
multimodality therapy including systemic antineoplastic and radiation therapy. Although this …